Phase II study of topotecan and bevacizumab in advanced, refractory non-small-cell lung cancer

Steven F. Powell, Amer Beitinjaneh, Mathewos Tessema, Robin L. Bliss, Robert A. Kratzke, Joseph Leach, Arkadiusz Z. Dudek

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of topotecan and bevacizumab in advanced, refractory non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences